Interferon-alpha polypeptides and conjugates

US7541163B2 · kind B2 · utility

Assignees

• Maxygen, Inc. · US
• Roche Palo Alto LLC · US

Inventors

• Phillip A. Patten · Portola Valley, US
• Sridhar Viswanathan · Menlo Park, US
• Torben Lauesgaard Nissen · Summit, US
• Anne Vogt · Hanau, DE
• Harald Kropshofer · Soest, DE
• Ralf Schumacher · Penzberg, DE
• Stephan Fischer · Weilheim, DE
• Stefan Seeber · Penzberg, DE
• Adelbert Grossmann · Murnau am Staffelsee, DE
• Friederike Hesse · Munich, DE

Key dates

• Filing date: Aug 14, 2007
• Grant date: Jun 2, 2009
• Expiry date: Sep 28, 2027

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.